Harvard Bioscience, Inc. Forecast, price target & analysts
Harvard Bioscience, Inc. Target price 2025 - Analyst rating & recommendation
Harvard Bioscience, Inc. Classifications & Recommendation:
Harvard Bioscience, Inc. Price Target
| Target Price | $3.06 |
| Price | $0.46 |
| Potential |
560.05%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Harvard Bioscience, Inc. 2026 .
The average Harvard Bioscience, Inc. target price is $3.06.
This is
560.05%
register free of charge
$3.15
579.47%
register free of charge
$3.03
553.58%
register free of charge
|
|
| A rating was issued by 8 analysts: 6 Analysts recommend Harvard Bioscience, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Harvard Bioscience, Inc. stock has an average upside potential 2026 of
560.05%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 94.14 | 88.89 |
| 16.13% | 5.57% | |
| EBITDA Margin | -0.13% | 8.32% |
| 101.83% | 6,627.04% | |
| Net Margin | -13.18% | 2.54% |
| 332.67% | 119.27% |
4 Analysts have issued a sales forecast Harvard Bioscience, Inc. 2025 . The average Harvard Bioscience, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Harvard Bioscience, Inc. EBITDA forecast 2025. The average Harvard Bioscience, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Harvard Bioscience, Inc. Analysts have issued a net profit forecast 2025. The average Harvard Bioscience, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.28 | 0.05 |
| 250.00% | 117.86% | |
| P/E | 9.09 | |
| EV/Sales | 0.57 |
4 Analysts have issued a Harvard Bioscience, Inc. forecast for earnings per share. The average Harvard Bioscience, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Harvard Bioscience, Inc....
Current Harvard Bioscience, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Benchmark |
Locked
➜
Locked
|
Locked | May 13 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| Benchmark |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Benchmark:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Apr 08 2025 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Mar 24 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
